Found: 778
Select item for more details and to access through your institution.
Colesevelam Plus Rosuvastatin 5 mg/Day Versus Rosuvastatin 10 mg/Day Alone on Markers of Insulin Resistance in Patients with Hypercholesterolemia and Impaired Fasting Glucose.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 3, p. 152, doi. 10.1089/met.2012.0103
- By:
- Publication type:
- Article
Strategies to Lower Low-Density Lipoprotein Cholesterol in Metabolic Syndrome: Averting the Diabetes Risk.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-γ Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A<sub>2</sub>
- Published in:
- Metabolic Syndrome & Related Disorders, 2011, v. 9, n. 3, p. 217, doi. 10.1089/met.2010.0120
- By:
- Publication type:
- Article
Rosuvastatin Alleviates Coronary Microembolization-Induced Cardiac Injury by Suppressing Nox2-Induced ROS Overproduction and Myocardial Apoptosis.
- Published in:
- Cardiovascular Toxicology, 2022, v. 22, n. 4, p. 341, doi. 10.1007/s12012-021-09716-4
- By:
- Publication type:
- Article
Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of β-Adrenergic Receptor Signaling.
- Published in:
- Cardiovascular Toxicology, 2021, v. 21, n. 5, p. 422, doi. 10.1007/s12012-021-09642-5
- By:
- Publication type:
- Article
Noncovalent Immobilization of Molecular Electrocatalysts for Chemical Synthesis: Efficient Electrochemical Alcohol Oxidation with a Pyrene-TEMPO Conjugate.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 30, p. 9018, doi. 10.1002/ange.201704921
- By:
- Publication type:
- Article
Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).
- Published in:
- Heart & Vessels, 2018, v. 33, n. 6, p. 590, doi. 10.1007/s00380-017-1094-0
- By:
- Publication type:
- Article
Statin-Induced Myopathy in a Patient with Schwartz-Jampel Syndrome.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 5, p. 1197, doi. 10.1177/08971900231213694
- By:
- Publication type:
- Article
Rhabdomyolysis Suspected to be Caused by Eravacycline Therapy: A Case Report.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 1, p. 239, doi. 10.1177/08971900221117872
- By:
- Publication type:
- Article
Statin-Associated Bilateral Foot Myopathy.
- Published in:
- Journal of Pharmacy Practice, 2020, v. 33, n. 6, p. 899, doi. 10.1177/0897190019857851
- By:
- Publication type:
- Article
RE: Praluent (Alirocumab)-Induced Renal Injury.
- Published in:
- Journal of Pharmacy Practice, 2018, v. 31, n. 2, p. 138, doi. 10.1177/0897190017734429
- By:
- Publication type:
- Article
Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment.
- Published in:
- Journal of Pharmacy Practice, 2017, v. 30, n. 5, p. 521, doi. 10.1177/0897190016674407
- By:
- Publication type:
- Article
Praluent (Alirocumab)-Induced Renal Injury.
- Published in:
- Journal of Pharmacy Practice, 2017, v. 30, n. 1, p. 7, doi. 10.1177/0897190016683304
- By:
- Publication type:
- Article
Relative Efficacy of Antilipemic Agents in Non–High-Density Lipoprotein Cholesterol Reduction.
- Published in:
- Journal of Pharmacy Practice, 2012, v. 25, n. 4, p. 447, doi. 10.1177/0897190012442722
- By:
- Publication type:
- Article
Do Statins Affect Thyroid Volume and Nodule Size in Patients with Hyperlipidemia in a Region with Mild-to-Moderate Iodine Deficiency? A Prospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An Efficient, Simultaneous Electrochemical Assay of Rosuvastatin and Ezetimibe from Human Urine and Serum Samples.
- Published in:
- Methods & Protocols, 2022, v. 5, n. 6, p. 90, doi. 10.3390/mps5060090
- By:
- Publication type:
- Article
Control and monitoring of lipoprotein levels in atherosclerosis induced rabbits using novel nanoparticulate medication of Lovastatin and Rosuvastatin.
- Published in:
- Micro & Nano Letters (Wiley-Blackwell), 2021, v. 16, n. 11, p. 558, doi. 10.1049/mna2.12081
- By:
- Publication type:
- Article
The dyslipidaemia market.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 11, p. 807, doi. 10.1038/nrd4475
- By:
- Publication type:
- Article
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.
- Published in:
- Cell Biology International, 2010, v. 34, n. 7, p. 709, doi. 10.1042/CBI20090473
- By:
- Publication type:
- Article
Development and validation of novel RP-HPLC method for the simultaneous determination of Rosuvastatin and Teneligliptin in bulk and in synthetic mixture.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 3, p. 498, doi. 10.31838/ijpr/2021.13.03.061
- By:
- Publication type:
- Article
Development and Validation of RP-HPLC Method for Determination of Amlodipine Besylate, Telmisartan and Rosuvastatin Calcium from Synthetic Mixture.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 5261, doi. 10.31838/ijpr/2021.13.01.704
- By:
- Publication type:
- Article
Development of Oral Self-Nanoemulsifying Drug Delivery System (SNEDDS) Of Rosuvastatin Calcium: Formulation, Characterization, And In-Vitro Drug Release Study.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 1334, doi. 10.31838/ijpr/2021.13.01.296
- By:
- Publication type:
- Article
Effects of statins on platelet count in hyperlipidemic patients.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 2, p. 2640, doi. 10.31838/ijpr/2020.12.02.357
- By:
- Publication type:
- Article
Evaluating the Effectiveness of Pharmacological Correction of Experimental Hyperlipidemia with a Combination of L-Ethoxidol and Rosuvastatin.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 2, p. 1646, doi. 10.31838/ijpr/2020.12.02.207
- By:
- Publication type:
- Article
Comparison of efficacy of rosuvastatin as cholesterol synthesis inhibitor with atorvastatin and simvastatin in patients with hypercholesterolemia.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 1, p. 305, doi. 10.31838/ijpr/2020.12.01.055
- By:
- Publication type:
- Article
Production of Rosuvastatin Calcium Nanoparticles Using Gas Antisolvent Technique: Experimental and Optimization.
- Published in:
- Periodica Polytechnica: Chemical Engineering, 2021, v. 65, n. 4, p. 442, doi. 10.3311/PPch.16629
- By:
- Publication type:
- Article
Effect of phospholipid-polymer conjugate on physical properties of Rosuvastatin/Ezetimibe loaded lipid-polymer hybrid nanoparticles.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 77, doi. 10.33320/maced.pharm.bull.2023.69.03.038
- By:
- Publication type:
- Article
Comparative review of self-nanoemulsifying drug delivery systems with Rosuvastatin.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 23, doi. 10.33320/maced.pharm.bull.2023.69.03.011
- By:
- Publication type:
- Article
Influence of organic to aqueous phase solvent volume ratio on the physicochemical characteristics of rosuvastatin and ezetimibe loaded lipid-polymer hybrid nanoparticles prepared by nanoprecipitation method.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 305, doi. 10.33320/maced.pharm.bull.2022.68.03.147
- By:
- Publication type:
- Article
Improvement of the analytical method for content determination of Rosuvastatin film coated tablets during lifecycle.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 69, doi. 10.33320/maced.pharm.bull.2022.68.03.030
- By:
- Publication type:
- Article
强力定眩片及联合他汀类对高脂血症小鼠的降脂作用.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 1, p. 29, doi. 10.13241/j.cnki.pmb.2023.01.006
- By:
- Publication type:
- Article
瑞舒伐他汀钙与非诺贝特联合治疗血脂异常的疗效及对肝肾功能的影响.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 6, p. 1077, doi. 10.13241/j.cnki.pmb.2021.06.017
- By:
- Publication type:
- Article
The lipid-lowering efficacy of rosuvastatin is associated with variations in SLCO1B1: a 12-month prospective cohort study.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 10, p. 4708
- By:
- Publication type:
- Article
Is rosuvastatin protective against sepsis-associated encephalopathy? A secondary analysis of the SAILS trial.
- Published in:
- World Journal of Emergency Medicine, 2022, v. 13, n. 5, p. 367, doi. 10.5847/wjem.j.1920-8642.2022.072
- By:
- Publication type:
- Article
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients.
- Published in:
- Open Forum Infectious Diseases, 2016, v. 3, n. 1, p. 1, doi. 10.1093/ofid/ofv201
- By:
- Publication type:
- Article
Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open‐Label, 1‐Sequence, Crossover Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 4, p. 486, doi. 10.1002/cpdd.1076
- By:
- Publication type:
- Article
Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 235, doi. 10.1002/cpdd.1015
- By:
- Publication type:
- Article
Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1290, doi. 10.1002/cpdd.926
- By:
- Publication type:
- Article
Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1335, doi. 10.1002/cpdd.957
- By:
- Publication type:
- Article
Evaluation of the Effects of Repeat‐Dose Dabrafenib on the Single‐Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate).
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1054, doi. 10.1002/cpdd.937
- By:
- Publication type:
- Article
Comparison of the Pharmacokinetics of a Fixed‐Dose Combination of Rosuvastatin/Metformin Sustained‐Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 207, doi. 10.1002/cpdd.841
- By:
- Publication type:
- Article
Effects of Multiple‐Dose Administration of Aprocitentan on the Pharmacokinetics of Rosuvastatin.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 995, doi. 10.1002/cpdd.815
- By:
- Publication type:
- Article
Application of a Backpropagation Artificial Neural Network in Predicting Plasma Concentration and Pharmacokinetic Parameters of Oral Single‐Dose Rosuvastatin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 867, doi. 10.1002/cpdd.809
- By:
- Publication type:
- Article
Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin, Formulation and Food on Oral Bioavailability.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 3, p. 411, doi. 10.1002/cpdd.756
- By:
- Publication type:
- Article
Effects of Food and Gender on Pharmacokinetics of Rosuvastatin in a Chinese Population Based on 4 Bioequivalence Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 2, p. 235, doi. 10.1002/cpdd.706
- By:
- Publication type:
- Article
The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 131, doi. 10.1002/cpdd.214
- By:
- Publication type:
- Article
Effect of CYP2C19 polymorphism on the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 1, p. 33, doi. 10.1002/cpdd.135
- By:
- Publication type:
- Article
Persistence of a proinflammatory status after treatment of the acute myocardial infarction.
- Published in:
- Geriatrics & Gerontology International, 2023, v. 23, n. 9, p. 700, doi. 10.1111/ggi.14649
- By:
- Publication type:
- Article
Efficacy of Senna Leaves Extract and Rosuvastatin on Blood Parameters of Inducing Hyperlipidemia Laboratory Rats.
- Published in:
- Alinteri Journal of Agriculture Sciences, 2022, v. 37, n. 1, p. 27, doi. 10.47059/alinteri/V37I1/AJAS22006
- By:
- Publication type:
- Article
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1136114
- By:
- Publication type:
- Article